Not just an ophthalmology-focused CRO, Iris Pharma helps clients around the world navigate every stage of the drug and device development process and delivers customized solutions for: 

•	Assessing possible therapeutic effect in ocular diseases
•	Adding value to promising drug candidates or medical devices
•	Designing development plans and preclinical packages and carrying out studies to proceed with confidence from bench to bedside
•	Providing the comprehensive clinical development services you need, from First-in-Human through Phase IV and Post-marketing follow-through

We accompany start-up companies, biotechnology companies, large pharmaceutical companies, pharmaceutical labs, universities, research organizations and consultants in their ophthalmology projects.

Our assets: 
•	32 years of experience in the field of ophthalmology research
•	All ophthalmic indications mastered
•	70+ FDA, PMDA & EMA new ocular drug approvals and ophthalmic medical device marketing authorizations
•	State-of-the-art medical and scientific equipment
•	Highly specialized and qualified staff
•	Statement of compliance with GLP and GCLP
•	Adherence to all trial-related requirements (ICH-GCP)
•	French research tax credit accreditation (CIR)

IRIS PHARMA

Yann Quentric

This department manages administrative tasks and financial record-keeping functions.

Administrative Services

This department oversees and coordinates clinical research activities and studies.

Clinical Research

This department provides strategic direction and overall management for the organization.

Executive Leadership

This department oversees the planning, execution, and management of preclinical research activities and strategies.

Preclinical Operations

This department oversees the management and execution of research studies.

IRIS PHARMA

Org chart

Teams

Administrative Services

Clinical Research

Executive Leadership

Preclinical Operations

Research Operations

Offices